New research demonstrates that individuals with prediabetes can substantially improve their long-term health outcomes by postponing the onset of type 2 diabetes for just four years through lifestyle modifications.
Gilead Sciences’ twice-yearly injectable lenacapavir demonstrated complete protection against HIV infection in a landmark Phase 3 trial, potentially revolutionising HIV prevention strategies for vulnerable populations.
A pioneering study from UC Berkeley has detected toxic metals, including arsenic and lead, in commercially available tampons. This unprecedented research raises urgent questions about potential health risks for millions of women who use these products and calls for increased scrutiny of feminine hygiene product safety.
A groundbreaking study led by Stanford Medicine researchers has unveiled six distinct biological subtypes of depression using brain imaging and machine learning techniques. This discovery could change the approach to diagnosing and treating depression, potentially leading to more effective, personalised interventions.
HKUMed team’s technology set to revolutionise liver cancer care A groundbreaking innovation in liver cancer treatment has earned international recognition for a team of researchers from the University of Hong Kong’s LKS Faculty of Medicine (HKUMed). Their ‘Bionic Liver-in-Cube: A Comprehensive Precise Theranostics for Liver Cancer and Diseases’ (‘Liver-in-Cube’) technology was awarded a Gold Medal […]
A comprehensive study published in The BMJ [1] reveals a complex picture of cardiovascular disease (CVD) trends in the UK over the past two decades. While rates of coronary heart disease have declined significantly, this progress has been offset by rising incidences of other cardiovascular conditions.
Researchers at the University of British Columbia have made a significant breakthrough in endometrial cancer diagnosis, utilising artificial intelligence (AI) to identify a previously unrecognised high-risk subtype. This discovery promises to enhance patient care for those with the most common gynaecological malignancy.
Researchers at Boston University have developed an artificial intelligence (AI) model that can predict with 78.5% accuracy whether individuals with mild cognitive impairment will progress to Alzheimer’s-associated dementia over a six-year period.
A groundbreaking study has unveiled a novel genetic factor contributing to obesity, shedding light on the complex interplay between genetics and body weight regulation.
Global trial results provide clarity on proton-pump inhibitor use A large international trial and updated systematic review have provided critical evidence supporting the use of the proton-pump inhibitor pantoprazole to prevent upper gastrointestinal (GI) bleeding in critically ill adults requiring mechanical ventilation.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
